Matthias Rau

1.3k total citations
29 papers, 934 citations indexed

About

Matthias Rau is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Matthias Rau has authored 29 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Cardiology and Cardiovascular Medicine and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Matthias Rau's work include Diabetes Treatment and Management (9 papers), Cardiac Valve Diseases and Treatments (7 papers) and Cardiac Imaging and Diagnostics (4 papers). Matthias Rau is often cited by papers focused on Diabetes Treatment and Management (9 papers), Cardiac Valve Diseases and Treatments (7 papers) and Cardiac Imaging and Diagnostics (4 papers). Matthias Rau collaborates with scholars based in Germany, Netherlands and Austria. Matthias Rau's co-authors include Christian W. Hamm, Michael Weber, Roland R. Brandt, Thorsten Dill, Román Arnold, Albrecht Elsaesser, Veselin Mitrović, Nikolaus Marx, Michael Lehrke and Anna S. John and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Matthias Rau

28 papers receiving 892 citations

Peers

Countries citing papers authored by Matthias Rau

Since Specialization

Citations

This map shows the geographic impact of Matthias Rau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Rau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Rau more than expected).

Fields of papers citing papers by Matthias Rau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Rau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Rau. The network helps show where Matthias Rau may publish in the future.

Co-authorship network of co-authors of Matthias Rau

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Rau. A scholar is included among the top collaborators of Matthias Rau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Rau. Matthias Rau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The gut hormone glucose-dependent insulinotropic polypeptide is downregulated in response to myocardial injury 2022 ·Cardiovascular Diabetology ·Florian Kahles, Matthias Rau, (unknown), Ann Christina Foldenauer, (unknown), (unknown), Jörg Schröder, (unknown), Julia Moellmann, Emiel P. C. van der Vorst, Nikolaus Marx, Michael Lehrke	1
2	Empagliflozin Reduces Markers of Acute Kidney Injury in Patients with Acute Decompensated Heart Failure 2022 ·ESC Heart Failure ·Kirsten Thiele, Matthias Rau, Niels‐Ulrik Korbinian Hartmann, (unknown), Julia Möllmann, Joachim Jankowski, András Keszei, Michael Böhm, Jürgen Floege, Nikolaus Marx, Michael Lehrke	24
3	Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes – Data from a randomized, placebo-controlled study 2022 ·Bone Reports ·Matthias Rau, Kirsten Thiele, Niels‐Ulrik Korbinian Hartmann, Julia Möllmann, Stephanie Wied, Mathias Hohl, Nikolaus Marx, Michael Lehrke	19
4	Effects of empagliflozin on lipoprotein subfractions in patients with type 2 diabetes: data from a randomized, placebo-controlled study 2021 ·Atherosclerosis ·Matthias Rau, Kirsten Thiele, Niels‐Ulrik Korbinian Hartmann, Julia Möllmann, Stephanie Wied, Michael Böhm, Hubert Scharnagl, Winfried März, Nikolaus Marx, Michael Lehrke	11
5	Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study 2021 ·Cardiovascular Diabetology ·Matthias Rau, Kirsten Thiele, Niels‐Ulrik Korbinian Hartmann, Alexander Schuh, Ertunc Altiok, Julia Möllmann, András Keszei, Michael Böhm, Nikolaus Marx, Michael Lehrke	46
6	Peptide YY (PYY) Is Associated with Cardiovascular Risk in Patients with Acute Myocardial Infarction 2020 ·Journal of Clinical Medicine ·(unknown), (unknown), Florian Kahles, Marcia Viviane Rückbeil, Matthias Rau, Julia Moellmann, Moritz Biener, Mohammad Almalla, (unknown), Evangelos Giannitsis, Hugo A. Katus, Nikolaus Marx, Michael Lehrke	7
7	Empagliflozin Leads to a Rapid and Sustained Improvement of Diastolic Function in Patients With Type 2 Diabetes Independent of Hemodynamic Changes 2019 ·Michael Lehrke, Kirsten Thiele, Matthias Rau, Ertunc Altiok, Michael Böhm, András Keszei, Nikolaus Marx, (unknown), (unknown)	1
8	The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE−/− mice by blocking monocyte/macrophage activation 2018 ·Molecular Metabolism ·Florian Kahles, Ana C. Liberman, (unknown), Matthias Rau, Julia Möllmann, (unknown), Marcia Viviane Rückbeil, (unknown), (unknown), (unknown), Mathias Burgmaier, Corinna Lebherz, Nikolaus Marx, Michael Lehrke	51
9	Argatroban for elective percutaneous coronary intervention: The ARG-E04 multi-center study 2010 ·International Journal of Cardiology ·Lothar Rössig, Sabine Genth‐Zotz, Matthias Rau, Guy R. Heyndrickx, Thomas Schneider, Dietrich C. Gulba, Martin Desaga, M. Buerke, S. Harder, Andreas M. Zeiher	19
10	Rapid effect of single-dose rosiglitazone treatment on endothelial function in healthy men with normal glucose tolerance: data from a randomised, placebo-controlled, double-blind study 2010 ·Diabetes and Vascular Disease Research ·Thomas Walcher, Daniel Walcher, Jürgen Hetzel, (unknown), Matthias Rau, Kilian Rittig, Bernd Balletshofer, Edzard Schwedhelm, Vinzenz Hombach, Rainer H. Böger, Wolfgang Köenig, Nikolaus Marx	10
11	Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent)™ 2007 ·EuroIntervention ·Henricus J. Duckers, Thomas Soullié, Peter den Heijer, Benno J. Rensing, Robbert de Winter, Matthias Rau, Harald Mudra, Sigmund Silber, Edouard Benit, Stefan Verheye, William Wijns, Patrick W. Serruys	106
12	Acute and Long-Term Results of Bifurcation Stenting (from the COroflex Registry) 2006 ·The American Journal of Cardiology ·(unknown), (unknown), (unknown), Matthias Rau, Frank Weber, Holger Mühling, Angelo Cioppa, Franz X. Kleber	11
13	Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease 2005 ·European Heart Journal ·Michael Weber, Román Arnold, Matthias Rau, Albrecht Elsaesser, Roland R. Brandt, Veselin Mitrović, Christian W. Hamm	102
14	Diagnostic utility of new immunoassays for the cardiac markers cTnI, myoglobin and CK-MB mass 2005 ·Clinical Biochemistry ·Michael Weber, Matthias Rau, Katharina Madlener, Albrecht Elsaesser, Dragić Banković, Veselin Mitrović, Christian W. Hamm	40
15	Treatment of in-stent restenosis with sirolimus-eluting-stents— 2005 ·Zeitschrift für Kardiologie ·Matthias Rau, Christian Maikowski, Michael Weber, (unknown), Albrecht Elsässer, Helge Möllmann, Christian W. Hamm	4
16	Cardiopulmonary exercise capacity increases in patients with atrial septal defect following transcatheter closure 2003 ·Journal of the American College of Cardiology ·Michael Weber, Thomas Neumann, Matthias Rau, Christian Maikowski, (unknown), Roland R. Brandt, (unknown), Christian W. Hamm	2
17	N-terminal pro-BNP as a biochemical marker for assessing severity of aortic stenosis 2003 ·Journal of the American College of Cardiology ·Michael Weber, Matthias Rau, Christian Maikowski, (unknown), (unknown), (unknown), Roland R. Brandt, Christian Hamm	2
18	Magnetic resonance to assess the aortic valve area in aortic stenosis 2003 ·Journal of the American College of Cardiology ·Anna S. John, Thorsten Dill, Roland R. Brandt, Matthias Rau, (unknown), Georg Bachmann, Christian W. Hamm	127
19	Systemic dissemination of nickel in patients with atrial septal defects following the implantation of the amplatzer septal occluder 2003 ·Journal of the American College of Cardiology ·Thomas Neumann, (unknown), Maria Burian, Michael Weber, Matthias Rau, Roland R. Brandt, Thorsten Dill, Christian W. Hamm	3
20	Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: No evidence for thrombus deposition with antiplatelet agents 2002 ·Journal of the American Society of Echocardiography ·Roland R. Brandt, Thomas Neumann, Jörg Neuzner, Matthias Rau, (unknown), Christian W. Hamm	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact